Cargando…

The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Lipoprotein-associated phospholipase A(2) (Lp-PLA2) is a new specific vascular inflammation biomarker that is carried by the lipoproteins in the blood and plays a prominent role in the pathogenesis of atherosclerosis. Increased Lp-PLA2 levels and impaired Lp-PLA2 distribution across high-density lip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baziar, Nima, Nasli-Esfahani, Ensieh, Djafarian, Kurosh, Qorbani, Mostafa, Hedayati, Mehdi, Mishani, Mahshid Abd, Faghfoori, Zeinab, Ahmaripour, Najva, Hosseini, Saeed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085885/ https://www.ncbi.nlm.nih.gov/pubmed/32256955 http://dx.doi.org/10.1155/2020/5850865

Ejemplares similares

Effect of Therapeutic Dose of Vitamin D on Serum Adiponectin and Glycemia in Vitamin D-Insufficient or Deficient Type 2 Diabetic Patients
por: Baziar, Nima, et al.
Publicado: (2014)

Hypertensive Disorders of Pregnancy: Assessing the Significance of Lp(a) and ApoB Concentrations in a Romanian Cohort
por: Abu-Awwad, Simona-Alina, et al.
Publicado: (2023)

ApoB and Non‐HDL Cholesterol Versus LDL Cholesterol for Ischemic Stroke Risk
por: Johannesen, Camilla D. L., et al.
Publicado: (2022)

Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes
por: Sánchez-Quesada, Jose Luis, et al.
Publicado: (2013)

Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA(2) in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome
por: Lee, Hyo-Sun, et al.
Publicado: (2016)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010)

Barriers to weight management in pregnant mothers with obesity: a qualitative study on mothers with low socioeconomic background
por: Mehrabi, Fahimeh, et al.
Publicado: (2021)

Utility of non-HDL-C and apoB targets in the context of new more aggressive lipid guidelines
por: Quispe, Renato, et al.
Publicado: (2021)

Amino acid profiling in the gestational diabetes mellitus
por: Rahimi, Najmeh, et al.
Publicado: (2017)

Healthy Dietary Pattern is Related to Blood Lipids in Patients with Type 1 Diabetes Mellitus: A Cross-sectional Study from a Developing Country
por: Sajjadpour, Zahra, et al.
Publicado: (2021)

Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

ApoA-I/A-II-HDL positively associates with apoB-lipoproteins as a potential atherogenic indicator
por: Kido, Toshimi, et al.
Publicado: (2017)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016)

The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and Paraoxonase-1 activity in type 2 diabetic male patients
por: Shidfar, Farzad, et al.
Publicado: (2012)

apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study
por: Zheng, Kang H., et al.
Publicado: (2019)

Preprocedural Lp(a) level and ApoB/ApoA-Ι ratio and the risk for contrast-induced acute kidney injury in patients undergoing emergency PCI
por: Tao, Jun, et al.
Publicado: (2021)

Investigation of human apoB48 metabolism using a new, integrated non‐steady‐state model of apoB48 and apoB100 kinetics
por: Björnson, E., et al.
Publicado: (2019)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022)

Comparison of Apolipoprotein (apoB/apoA-I) and Lipoprotein (Total Cholesterol/HDL) Ratio Determinants. Focus on Obesity, Diet and Alcohol Intake
por: Tognon, Gianluca, et al.
Publicado: (2012)

Association of serum uric acid with nephropathy in Iranian type 2 diabetic patients
por: Razi, Farideh, et al.
Publicado: (2018)

Diabetes management during Ramadan amid Covid-19 pandemic
por: Tootee, Ali, et al.
Publicado: (2020)

Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
por: Tootee, Ali, et al.
Publicado: (2022)

The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study
por: Qin, Guangming, et al.
Publicado: (2015)

Lipid Profile, Lp(a) Levels, and HDL Quality in Adolescents with Down Syndrome
por: Krzesińska, Aleksandra, et al.
Publicado: (2022)

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases
por: De Stefano, Alessandro, et al.
Publicado: (2019)

Association between Lp-PLA2 and coronary heart disease in Chinese patients
por: Yang, Li, et al.
Publicado: (2017)

The changes of Lp-PLA2 in patients with gestational diabetes and its clinical significance
por: Wang, Guo-Hua, et al.
Publicado: (2021)

Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease
por: Wu, Linlin, et al.
Publicado: (2023)

Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus
por: Hashemian, Seyed Jafar, et al.
Publicado: (2015)

Effect of the different assays of HbA1c on diabetic patients monitoring
por: Razi, Farideh, et al.
Publicado: (2015)

A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents
por: Djalalinia, Shirin, et al.
Publicado: (2016)

Regulation of plasma LDL: the apoB paradigm
por: Sniderman, Allan D., et al.
Publicado: (2009)

LDL-cholesterol measurement in diabetic type 2 patients: a comparison between direct assay and popular equations
por: Razi, Farideh, et al.
Publicado: (2017)

COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran
por: Peimani, Maryam, et al.
Publicado: (2022)

Can Following Paleolithic and Mediterranean Diets Reduce the Risk of Stress, Anxiety, and Depression: A Cross-Sectional Study on Iranian Women
por: Zamani, Behzad, et al.
Publicado: (2023)

How is healthy eating index-2015 related to risk factors for cardiovascular disease in patients with type 2 diabetes
por: Zeinalabedini, Mobina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96fpads5658tc7uk6rcg80gkvn